Myelo Therapeutics GmbH, a clinical-stage pharmaceutical company focused on developing medical countermeasures (MCM) and therapies for cancer supportive care, announced today that the U.S. National Institute of Allergy and Infectious Diseases…
Eckert & Ziegler (ISIN DE0005659700, TecDAX) and Telix Pharmaceuticals (Telix) will cooperate closely in the commercialization of GalliaPharm® (68Ge/68Ga Generator) and investigational product Illuccix® (Kit for the preparation of Ga-68 PSMA-11…
Deadline: June 20th, 2021
The Growth Track is our offer for early to mid-stage startups. This track is a good fit for Seed and Series A startups with a minimal viable product validated through patents and publications. And of course, a stellar and…
Berlin-based biotech Bluu Biosciences has closed its seed funding round at 7 million euros less than ten months after its foundation. Bluu Biosciences is the first company in Europe to specialize in the development and production of cell-based fish.…
The company will enhance accessibility to medicines for Egypt, the Middle East and Africa while strengthening regional and local manufacturing capacities
Join one of our webinars to gain insights about this year’s partnership opportunities for digital health innovators with Bayer G4A!
We will reflect on the implications of the Covid-19 pandemic for digital health…
Berlin, May 12, 2021 - Today the 15th Speed Lecture Award took place as part of BIONNALE, again as a live-stream and with over 750 registrations.
One-off effects from the deconsolidation of the tumor irradiation business, a waning of the Corona slump, and continued strong demand in particular for pharmaceutical radioisotopes more than doubled net profit at Eckert & Ziegler Strahlen- und…
A collaboration between Berlin, London, New York and Paris to leverage our collective innovation and speed our recovery from Covid-19
Investment will strengthen technology and expand company’s reach
